
WFRV/HealthWatch: Lifting brain fog with virtual music therapy
University of Cincinnati researchers' pilot study provides do-it-yourself intervention through app
Patients who have been infected with COVID-19 or who have gone through medical treatment like chemotherapy often report brain fog, described as issues with thinking, remembering or focusing.
University of Cincinnati researchers led by Soma Sengupta, MD, PhD, associate professor and Harold C. Schott Endowed Chair of Molecular Therapeutics in the Department of Neurology and a UC Health neuro-oncologist; and Claudia Rebola, PhD, associate dean for research, associate professor and director of the new Center for DAAP Research and Innovation (CDRI) on Health and Wellbeing in the College of Design, Architecture, Art, and Planning, are leading a pilot study examining music therapy's effect on brain fog through a mobile app.
Patients in the study are assigned to groups that either listen to music or actively make their own music through the app.
“These technologies are sort of in a way helping the rewiring and exercising areas of the brain that normally wouldn’t do it,” Sengupta told WFRV's HealthWatch.
Featured photo of ARMCan app in use courtesy of Claudia Rebola, PhD.
Related Stories
Students are spending the summer researching cures
May 21, 2025
Siobain Knox and Eric Kniffen are biology students who plan to work in the medical field to help improve and possibly save lives. They are both getting hands-on experience this summer through two separate, highly competitive research fellowships with area hospitals.
Hoxworth Blood Center to host community blood drives honoring...
May 21, 2025
Hoxworth Blood Center, University of Cincinnati, is partnering with two local schools to host community blood drives that honor the lives of local patients and highlight the critical need for blood donors in the Greater Cincinnati area.
UC study: Engineered bacteria can deliver antiviral therapies,...
May 21, 2025
New research led by the University of Cincinnati’s Nalinikanth Kotagiri recently published in the journal Gut Microbes demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.